Genetics of dementia.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Lancet

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0140-6736(13)60630-3PMID 23927914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• Genetic insights in Alzheimer's disease.

  2013cited by this paper
• The Genetics of Dementia

  2013cited by this paper
• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013cited by this paper
• Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

  2012cited by this paper
• Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features

  2012cited by this paper
• Genetics of dementia: Update and guidelines for the clinician

  2012cited by this paper
• Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.

  2012cited by this paper
• The autosomal recessive cerebellar ataxias.

  2012cited by this paper
• Complex single gene disorders and epilepsy

  2012cited by this paper
• Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease.

  2012cited by this paper
• Evidence for an oligogenic basis of amyotrophic lateral sclerosis.

  2012cited by this paper
• C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts

  2012cited by this paper
• Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study

  2012cited by this paper
• Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics

  2012cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Primary progressive aphasia

  2012cited by this paper
• Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families

  2012cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• [The logopenic variant of primary progressive aphasia].

  2011cited by this paper
• Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.

  2011cited by this paper
• Exome sequencing allows for rapid gene identification in a Charcot‐Marie‐Tooth family

  2011cited by this paper
• The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.

  2011cited by this paper
• p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

  2011cited by this paper
• Phenotypic signatures of genetic frontotemporal dementia.

  2011cited by this paper
• Exome sequencing as a tool for Mendelian disease gene discovery

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres

  2011cited by this paper
• Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)

  2011cited by this paper
• Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p

  2011cited by this paper
• The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.

  2011cited by this paper
• Clinical molecular diagnosis of Wilson disease.

  2011cited by this paper
• Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype

  2011cited by this paper
• Genetics of Dementia

  2011cited by this paper
• An algorithm for genetic testing of frontotemporal lobar degeneration

  2011cited by this paper
• Potential Mechanisms of Progranulin-deficient FTLD

  2011cited by this paper
• New agents and approaches to treatment in Niemann-Pick type C disease.

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors

  2011cited by this paper
• Individual genomes on the horizon.

  2010cited by this paper
• TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.

  2010influential reference
• Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

  2010cited by this paper
• Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

  2010cited by this paper
• Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

  2010cited by this paper
• Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis

  2010cited by this paper
• Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology.

  2010cited by this paper
• Clinical Spectrum of CADASIL and the Effect of Cardiovascular Risk Factors on Phenotype: Study in 200 Consecutively Recruited Individuals

  2010cited by this paper
• Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases.

  2010cited by this paper
• Exome sequencing reveals VCP mutations as a cause of familial ALS.

  2010cited by this paper
• The logopenic variant of primary progressive aphasia.

  2010cited by this paper
• Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.

  2010cited by this paper
• TARDBP Mutations in Frontotemporal Lobar Degeneration: Frequency, Clinical Features, and Disease Course

  2010cited by this paper
• Genetic Causes of Frontotemporal Degeneration

  2010cited by this paper
• The diagnosis of young-onset dementia.

  2010cited by this paper
• Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

  2010cited by this paper
• The genetics of Parkinson's syndromes: a critical review.

  2009cited by this paper
• How to use an article about genetic association: A: Background concepts.

  2009cited by this paper
• Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases.

  2009cited by this paper
• Genetic risk prediction--are we there yet?

  2009cited by this paper
• Cadasil.

  2009cited by this paper
• FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis

  2009cited by this paper
• P3‐158: Familial aggregation of dementia with lewy bodies

  2009cited by this paper
• Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

  2009cited by this paper
• [Autosomal recessive cerebellar ataxias].

  2009cited by this paper
• Systematic Review: Family History in Risk Assessment for Common Diseases

  2009cited by this paper
• The heritability and genetics of frontotemporal lobar degeneration

  2009cited by this paper
• Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

  2009cited by this paper
• Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

  2009cited by this paper
• The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

  2009cited by this paper
• Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.

  2008cited by this paper
• Recent advances in the genetics of dementia with Lewy bodies

  2008cited by this paper
• Mutations in TREM2 lead to pure early‐onset dementia without bone cysts

  2008cited by this paper
• DLB and PDD boundary issues

  2007cited by this paper
• The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test

  2007cited by this paper
• Detection of Huntington’s disease decades before diagnosis: the Predict-HD study

  2007cited by this paper
• Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation

  2007cited by this paper
• Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.

  2007cited by this paper
• Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease

  2007cited by this paper
• Wilson's disease

  2007cited by this paper
• Neuropsychological deficits in frontotemporal dementia and Alzheimer’s disease: a meta-analytic review

  2007cited by this paper
• Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia (bvFTD): Current Limitations and Future Directions

  2007cited by this paper
• Huntington's disease.

  2007cited by this paper
• Knowledge of and Attitudes about Alzheimer Disease Genetics: Report of a Pilot Survey and Two Focus Groups

  2007cited by this paper
• Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

  2006cited by this paper
• The adult form of Niemann-Pick disease type C.

  2006cited by this paper
• Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

  2006cited by this paper
• APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

  2006cited by this paper
• Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

  2006cited by this paper
• Prion disease genetics

  2006cited by this paper
• Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD

  2005cited by this paper
• Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.

  2005cited by this paper
• Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update

  2005cited by this paper
• Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia

  2005cited by this paper
• Pick bodies in a family with presenilin‐1 Alzheimer's disease

  2005cited by this paper
• Genetic linkage studies.

  2005cited by this paper

• Association of frailty and mortality risk in community-dwelling older adults: a systematic review and meta-analysis of 59 international prospective cohort studies

  2026cites this paper
• Apolipoprotéine E et maladie d’Alzheimer : mécanismes moléculaires et implications thérapeutiques à l’ère du lecanemab

  2026cites this paper
• Region-specific brain structural modulation and amyloid-β pathology associated with dietary biotin: insights into dementia neuropathology.

  2026cites this paper
• The causal effects of dementia on systemic sclerosis: a two-sample bidirectional Mendelian randomization study.

  2026cites this paper
• Pterosin D-activated protein kinase A mitigates Alzheimer's disease in 5xFAD mice

  2025cites this paper
• 2025 Alzheimer's disease facts and figures

  2025cites this paper
• Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report

  2025cites this paper
• Epidemiology and Risk Factors Characteristics of Alzheimer’s Disease in Southwestern China: A Cross-Sectional Study

  2025cites this paper
• Bidirectional Mediation of Cognition by DNA Methylation and Lean Body Mass in Chinese Monozygotic Twins

  2025cites this paper
• Associations of age at menopause, bilateral oophorectomy, hysterectomy and hormone replacement therapy with glycaemia and risk of dementia: a study based on the population-based UK Biobank cohort

  2025cites this paper
• The Present and Future Dementia Burden in China: Kinship-Based Projections and Global Comparisons.

  2025cites this paper
• Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction

  2025cites this paper
• Harnessing Artificial Intelligence for Transforming Dementia Care: Innovations in Early Detection and Treatment

  2025cites this paper
• Association of Predicted Visceral Fat Percentage With Dementia Risk in Older Adults

  2025cites this paper
• Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease

  2025cites this paper
• The promise of gene therapy in common types of dementia

  2025cites this paper
• A thematic analysis of Lay knowledge and beliefs about dementia among first-generation Black African immigrants from West Africa living in London: Informed by a grounded theory approach

  2025cites this paper
• Reevaluating the role of biological aging in dementia: A retrospective cross-sectional global analysis incorporating confounding factors.

  2025cites this paper
• Targeting HIF-P4H-2 in APP/PS1 Alzheimer’s mouse model improves glucose metabolism, reduces dystrophic neuritis, and maintains exploratory activity

  2025cites this paper
• Heat shock protein 70 in Alzheimer's disease and other dementias: A possible alternative therapeutic

  2025cites this paper
• Cortical microstructure in familial frontotemporal dementia associated with MAPT, GRN, and C9orf72 pathogenic variants: Looking beyond atrophy

  2025cites this paper
• Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives.

  2025cites this paper
• Association of statins use and genetic susceptibility with incidence of Alzheimer's disease

  2025cites this paper
• Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review

  2025cites this paper
• Summary-data-based Mendelian Randomization Analysis Identifies Nominal Evidence for Association of N6-Methyladenosine Genetic Variation with Alzheimer’s Disease

  2025cites this paper
• Association between midday napping and long-term trajectories of cognitive function among middle-aged and older Chinese adults

  2025cites this paper
• Predictive Accuracy of a Clinical Model for Carriage of Pathogenic/Likely Pathogenic Variants in Patients with Dementia and a Positive Family History at PUMCH

  2025influential citation
• Are modifiable risk factors for dementia really modifiable?

  2025cites this paper
• A novel SORL1 mutation in a pedigree affected by early-onset Alzheimer's disease

  2025cites this paper
• The interaction between circadian syndrome and genetic susceptibility in the risk of incident dementia: A longitudinal cohort study

  2025cites this paper
• APOE genotype and cognitive decline: Educational context as a moderator of genetic risk.

  2025cites this paper
• 2024 Alzheimer's disease facts and figures

  2024cites this paper
• Hormone Replacement Therapy and Alzheimer’s Disease: Current State of Knowledge and Implications for Clinical Use

  2024cites this paper
• The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need

  2024cites this paper
• Dementia

  2024cites this paper
• The vascular contribution of apolipoprotein E to Alzheimer's disease.

  2024cites this paper
• Physical frailty predicts cognitive decline among community-dwelling older Japanese women: A prospective cohort study from the Otassha study.

  2024cites this paper
• Association of cognitive reserve with the risk of dementia in the UK Biobank: role of polygenic factors

  2024cites this paper
• The Potential Role of Enrichment Environment on Plasticity in Alzheimer's Disease Models: Insights About Therapeutic Approaches.

  2024cites this paper
• Association of long-term exposure to various ambient air pollutants, lifestyle, and genetic predisposition with incident cognitive impairment and dementia

  2024cites this paper
• Steroidogenic Acute Regulatory Protein Mediated Variations of Gender-Specific Sex Neurosteroids in Alzheimer's Disease: Relevance to Hormonal Imbalance.

  2024cites this paper
• The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases

  2024cites this paper
• Genetic testing in dementia

  2024cites this paper
• Dementia in Australia: Clinical recommendations post‐diagnosis

  2024cites this paper
• Presenilin Gene Mutation-associated Psychosis

  2024cites this paper
• Joint Exposure to Multiple Air Pollutants, Genetic Susceptibility, and Incident Dementia: A Prospective Analysis in the UK Biobank Cohort

  2024cites this paper
• The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review.

  2024cites this paper
• Microglial Transforming Growth Factor-β Signaling in Alzheimer’s Disease

  2024cites this paper
• Impact of APOE, Klotho, and sex on cognitive decline with aging

  2024cites this paper
• Potential application of aptamers combined with DNA nanoflowers in neurodegenerative diseases.

  2024cites this paper
• Occlusion dysfunction and Alzheimer’s disease: Mendelian randomization study

  2024cites this paper
• Predicting dementia in Parkinson's disease on a small tabular dataset using hybrid LightGBM–TabPFN and SHAP

  2024cites this paper
• Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates.

  2024cites this paper
• Optimizing Machine Learning Models for Accessible Early Cognitive Impairment Prediction: A Novel Cost-Effective Model Selection Algorithm

  2024cites this paper
• Design and Rationale of a Two-Armed Randomized Controlled Trial on Yoga/Brisk Walking-Based Lifestyle Modification on Dementia Risk Reduction, and Influence of ApoE Genotypes on the Intervention

  2024cites this paper
• Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer’s disease

  2024cites this paper
• Physical frailty, genetic predisposition, and incident dementia: a large prospective cohort study

  2024cites this paper
• MAMs and Mitochondrial Quality Control: Overview and Their Role in Alzheimer’s Disease

  2024cites this paper
• Using the Theory of Planned Behavior and Past Behavior to Explain the Intention to Receive a Seasonal Influenza Vaccine among Family Caregivers of People with Dementia

  2023cites this paper
• Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia

  2023cites this paper
• Questionnaires for the Assessment of Cognitive Function Secondary to Intake Interviews in In-Hospital Work and Development and Evaluation of a Classification Model Using Acoustic Features

  2023cites this paper
• Editorial: Current advances in genetic presentations of dementia and aging, volume II

  2023cites this paper
• Dementia, infections and vaccines: 30 years of controversy

  2023cites this paper
• Enriched environment as a nonpharmacological neuroprotective strategy

  2023cites this paper
• Evaluating the General Population of Saudi Arabia for Their Knowledge, Attitudes, and Practices Towards Dementia

  2023cites this paper
• Fecal microbiota transplantation: a novel strategy for treating Alzheimer’s disease

  2023cites this paper
• A 12-Year Comparison of Alzheimer’s Dementia Patients With Their Informants in Taiwan

  2023cites this paper
• Views of stakeholders at risk for dementia about deep brain stimulation for cognition.

  2023cites this paper
• Development and validation of LC-MS/MS method for quantitation of sodium oligomannate in human plasma, urine and feces.

  2023cites this paper
• Case of Autosomal Dominant Alzheimer Disease With Negative Findings From PiB-PET Examination

  2023cites this paper
• The shared genetic risk factors between Tourette syndrome and obsessive-compulsive disorder

  2023cites this paper
• 2023 Alzheimer's disease facts and figures

  2023cites this paper
• Leisure-Time Television Viewing and Computer Use, Family History, and Incidence of Dementia

  2023cites this paper
• Sex differences in longitudinal changes of episodic memory-related brain activity and cognition in cognitively unimpaired older adults with a family history of Alzheimer’s disease

  2023cites this paper
• Risk, protective, and biomarkers of dementia in Indigenous peoples: A systematic review

  2023cites this paper
• Effects of a physical exercise or motor activity protocol on cognitive function, lipid profile, and BDNF levels in older adults with mild cognitive impairment

  2023cites this paper
• Contribution of Chronic Sleep Deprivation to Age-Related Neurodegeneration in a Mouse Model of Familial Alzheimer’s Disease (5xFAD)

  2023cites this paper
• Cerebellar EEG source localization reveals age-related compensatory activity moderated by genetic risk for Alzheimer's disease.

  2023cites this paper
• Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy

  2023cites this paper
• Knowledge and attitudes of community pharmacists regarding dementia: A nationwide cross‐sectional study in Vietnam

  2023cites this paper
• Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms

  2023cites this paper
• BIN1 rs744373 SNP and APOE alleles specifically associate to common diseases

  2022cites this paper
• The Prevalence of Comorbidities and Associated Factors among Patients with Dementia in the Indian Setting: Meta-analysis of Observational Studies

  2022cites this paper
• Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets

  2022cites this paper
• Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer’s disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations

  2022cites this paper
• Activation of the hypoxia response protects mice from amyloid-β accumulation

  2022cites this paper
• A Preliminary Assessment of the Nutraceutical Potential of Acai Berry (Euterpe sp.) as a Potential Natural Treatment for Alzheimer’s Disease

  2022cites this paper
• The associations of APP , PSEN1 , and PSEN2 genes with Alzheimer's disease: A large case–control study in Chinese population

  2022cites this paper
• Incidence, morbidity, mortality and disparities in dementia: A population linked electronic health records study of 4.3 million individuals

  2022cites this paper
• Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.

  2022cites this paper
• Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• ZNF384: A Potential Therapeutic Target for Psoriasis and Alzheimer’s Disease Through Inflammation and Metabolism

  2022cites this paper
• 2022 Alzheimer's disease facts and figures

  2022cites this paper
• Development of a Sex-Specific Risk Scoring System for the Prediction of Cognitively Normal People to Patients With Mild Cognitive Impairment (SRSS-CNMCI)

  2022cites this paper
• Large household reduces dementia mortality: A cross-sectional data analysis of 183 populations

  2022cites this paper
• Study of Alzheimer's disease- and frontotemporal dementia-associated genes in the Cretan Aging Cohort.

  2022cites this paper
• Alzheimer’s Disease: Treatment Strategies and Their Limitations

  2022cites this paper
• ADAM10‐ and γ‐secretase‐dependent cleavage of the transmembrane protein PTPRT attenuates neurodegeneration in the mouse model of Alzheimer's disease

  2022cites this paper
• Update on Major Neurocognitive Disorders.

  2021cites this paper
• Visual Impairment and Risk of Dementia in 2 Population-Based Prospective Cohorts: UK Biobank and EPIC-Norfolk

  2021cites this paper